Logo image
Alzheimer's blood-based biomarkers, incident dementia, and interactions with age, APOE status, and hormone therapy
Journal article   Open access   Peer reviewed

Alzheimer's blood-based biomarkers, incident dementia, and interactions with age, APOE status, and hormone therapy

Michelle M Mielke, Sarah A Gaussoin, Ramon Casanova, Lauren A Latham, JoAnn E Manson, Charles P Mouton, Ted K S Ng, Stephen R Rapp, Susan M Resnick, Bonnie C Sachs, …
Alzheimer's & dementia, Vol.22(7), e71704
07/2026
DOI: 10.1002/alz.71704
PMID: 42509652
url
https://doi.org/10.1002/alz.71704View
Published (Version of record) Open Access

Abstract

Cognitive impairment among older adults is often due to multiple pathologies and heterogenous risk factors. We assessed whether Alzheimer's blood-based biomarkers (BBMs) were associated with incident mild cognitive impairment (MCI)/probable dementia, and whether associations were modified by age, apolipoprotein E (APOE), and hormone therapy (HT). Analyses included 2467 Women's Health Initiative Memory Study women (≥65 years of age) randomized between 1995 and 1998 to 3-5-years of HT or placebo. Cox regression (mean 18-year follow-up) assessed associations between the z-scored BBMs and MCI/dementia. Lower baseline amyloid beta (Aβ)42/40 ratio and higher phosphorylated tau 181 (p-tau181), glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) were associated with an increased risk of MCI and dementia; GFAP was most strongly associated. The p-tau181 and NfL associations were stronger among APOE ε4 carriers; BBMs varied non-linearly by age. The associations of BBMs with the cognitive outcomes also varied inconsistently between HT groups. BBMs for AD and related dementias (ADRD) are associated with incident MCI/dementia in older women. Interactions between the BBMs and HT were inconsistent and require further investigation.
Age Factors Aged Aged, 80 and over Alzheimer Disease - blood Amyloid beta-Peptides - blood Apolipoproteins E - genetics Biomarkers - blood Cognitive Dysfunction - blood Cognitive Dysfunction - epidemiology Cognitive Dysfunction - genetics Dementia - blood Dementia - epidemiology Dementia - genetics Female Glial Fibrillary Acidic Protein - blood Humans Incidence Neurofilament Proteins - blood Peptide Fragments - blood tau Proteins - blood

Details

Metrics

5 Record Views
Logo image